Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma

por Welsh, Sarah J., Corrie, Pippa G.
Publicado no Ther Adv Med Oncol (2015)

Seasonal variation in diagnosis of invasive cutaneous melanoma in Eastern England and Scotland

por Walter, Fiona M., Abel, Gary A., Lyratzopoulos, Georgios, Melia, Jane, Greenberg, David, Brewster, David H., Butler, Helen, Corrie, Pippa G., Campbell, Christine
Publicado no Cancer Epidemiol (2015)

Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma Model

por Lau, Doreen, Garçon, Fabien, Chandra, Anita, Lechermann, Laura M., Aloj, Luigi, Chilvers, Edwin R., Corrie, Pippa G., Okkenhaug, Klaus, Gallagher, Ferdia A.
Publicado no Front Immunol (2020)

Severe steroid-resistant anti-PD1 T-cell checkpoint inhibitor-induced hepatotoxicity driven by biliary injury

por Doherty, Gary Joseph, Duckworth, Adam M, Davies, Susan E, Mells, George F, Brais, Rebecca, Harden, Susan V, Parkinson, Christine A, Corrie, Pippa G
Publicado no ESMO Open (2017)

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial

por Lipplaa, Astrid, Fernandes, Ricardo, Marshall, Andrea, Lorigan, Paul, Dunn, Janet, Myers, Kevin A., Barker, Emily, Newton-Bishop, Julia, Middleton, Mark R., Corrie, Pippa G.
Publicado no Br J Cancer (2018)

Protocol for the OUTREACH trial: a randomised trial comparing delivery of cancer systemic therapy in three different settings - patient's home, GP surgery and hospital day unit

por McCrone Paul, Sabes-Figuera Ramon, Parker Richard A, Prevost Toby, Bavister Linda, Wood Victoria, Moody Margaret, Corrie Pippa G, Balsdon Helen, McKinnon Karen, O'Sullivan Brendan, Tan Ray S, Barclay Stephen IG
Publicado em 2011-10-01

Protocol for the OUTREACH trial: a randomised trial comparing delivery of cancer systemic therapy in three different settings - patient's home, GP surgery and hospital day unit

por Corrie, Pippa G, Moody, Margaret, Wood, Victoria, Bavister, Linda, Prevost, Toby, Parker, Richard A, Sabes-Figuera, Ramon, McCrone, Paul, Balsdon, Helen, McKinnon, Karen, O'Sullivan, Brendan, Tan, Ray S, Barclay, Stephen IG
Publicado em 2011

Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma

por Gill, Andrew B., Rundo, Leonardo, Wan, Jonathan C. M., Lau, Doreen, Zawaideh, Jeries P., Woitek, Ramona, Zaccagna, Fulvio, Beer, Lucian, Gale, Davina, Sala, Evis, Couturier, Dominique-Laurent, Corrie, Pippa G., Rosenfeld, Nitzan, Gallagher, Ferdia A.
Publicado no Cancers (Basel) (2020)

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancre...

por Strauss, Victoria Y., Shaw, Rachel, Virdee, Pradeep S., Hurt, Christopher N., Ward, Elizabeth, Tranter, Bethan, Patel, Neel, Bridgewater, John, Parsons, Philip, Radhakrishna, Ganesh, O’Neill, Eric, Sebag-Montefiore, David, Hawkins, Maria, Corrie, Pippa G., Maughan, Timothy, Mukherjee, Somnath
Publicado no BMC Cancer (2019)

Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial

por Backen, Alison C., Lopes, Andre, Wasan, Harpreet, Palmer, Daniel H, Duggan, Marian, Cunningham, David, Anthoney, Alan, Corrie, Pippa G., Madhusudan, Srinivasan, Maraveyas, Anthony, Ross, Paul J., Waters, Justin S., Steward, William P., Rees, Charlotte, McNamara, Mairéad G., Beare, Sandy, Bridgewater, John A., Dive, Caroline, Valle, Juan W.
Publicado no Br J Cancer (2018)

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients

por S. Ahmad, Saif, Qian, Wendi, Ellis, Sarah, Mason, Elaine, Khattak, Muhammad A., Gupta, Avinash, Shaw, Heather, Quinton, Amy, Kovarikova, Jarmila, Thillai, Kiruthikah, Rao, Ankit, Board, Ruth, Nobes, Jenny, Dalgleish, Angus, Grumett, Simon, Maraveyas, Anthony, Danson, Sarah, Talbot, Toby, Harries, Mark, Marples, Maria, Plummer, Ruth, Kumar, Satish, Nathan, Paul, Middleton, Mark R., Larkin, James, Lorigan, Paul, Wheater, Matthew, Ottensmeier, Christian H., Corrie, Pippa G.
Publicado no Melanoma Res (2015)

The care of older cancer patients in the United Kingdom

por Gomes, Fabio, Lewis, Anna, Morris, Rob, Parks, Ruth, Kalsi, Tania, Babic-Illamn, Gordana, Baxter, Mark, Colquhoun, Kirsty, Rodgers, Lisa, Smith, Eleanor, Greystoke, Alastair, Bayman, Neil, Cree, Anthea, Ng, Cassandra, de Liguori Carino, Nicola, Basile, Simone, Moore, John, Merchant, Zoe, Swinson, Daniel, Parbhoo, Anita, Jones, Rachel, Davies, Eleri, Danson, Sarah J, Young, Robin, Morgan, Jenna, Wyld, Lynda, Corrie, Pippa G, Doherty, Gary J, Crawford, Kyle, Wright, Juliet, Reed, Malcolm, Ugolini, Fiammetta, Lind, Michael, Cheung, Kwok-Leung, Harari, Danielle, Simcock, Richard
Publicado no Ecancermedicalscience (2020)

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

por Cebon, Jonathan S, Gore, Martin, Thompson, John F, Davis, Ian D, McArthur, Grant A, Walpole, Euan, Smithers, Mark, Cerundolo, Vincenzo, Dunbar, P Rod, MacGregor, Duncan, Fisher, Cyril, Millward, Michael, Nathan, Paul, Findlay, Michael P N, Hersey, Peter, Evans, T R Jeffry, Ottensmeier, Christian Hermann, Marsden, Jeremy, Dalgleish, Angus G, Corrie, Pippa G, Maria, Marples, Brimble, Margaret, Williams, Geoff, Winkler, Sintia, Jackson, Heather M, Endo-Munoz, Liliana, Tutuka, Candani S A, Venhaus, Ralph, Old, Lloyd J, Haack, Dennis, Maraskovsky, Eugene, Behren, Andreas, Chen, Weisan
Publicado no J Immunother Cancer (2020)